Accueil > Actualité
Actualite financiere : Actualite bourse

GSK: gets positive opinion for long-acting HIV treatment

( - GSK's ViiV Healthcare said that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending its long-acting treatment of HIV, that can be dosed once-monthly or once every two-months.

The recommendation is for a combination of Vocabria injection and tablets with Rekambys injection and Edurant tablets in adults who are still virologically suppressed on a stable antiretroviral regimen.

If approved, the treatment would become the first complete long-acting regimen, dosed once-monthly or once every 2-months, for virologically suppressed people living with HIV-1 across Europe.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.